Salivary uric acid as a non-invasive marker of early onset preeclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20230813Keywords:
Feto-maternal outcome, Preeclampsia, Salivary uric acid, Serum uric acidAbstract
Background: Preeclampsia is one of the most common complications in pregnancy and is a major cause of maternal and perinatal morbidity and mortality. Early prediction of preeclampsia is crucial in proactive management of the patient. Uric acid is a biomarker of hypertension.
Methods: A prospective study was done on 200 pregnant females in their first or early second trimester of pregnancy and were followed till one week of delivery or termination of pregnancy. After taking socio-demographic details, detailed medical and obstetric history was taken. Blood pressure of the patients was routinely measured and mean arterial pressure was calculated. Blood and saliva samples were taken and were analysed following standard protocol for serum and salivary uric acid levels respectively. Participants were classified into normotensive and preeclampsia groups depending on the criteria met.
Results: Preeclampsia group participants had significantly more adverse and feto-maternal outcomes. Salivary uric acid is a promising diagnostic predictor of preeclampsia in pregnant women by the virtue of being a non-invasive investigation with cut off value 4.86 mg/dl having a sensitivity of 70.8%, specificity of 45.7% and a PPV of 81.3%. Salivary uric acid level and mean arterial pressure were found to be better predictors of preeclampsia as compared to salivary uric acid level.
Conclusions: Salivary uric acid is a reliable predictor of preeclampsia in pregnant females in first and early second trimester of pregnancy. Further largescale studies are warranted to establish an accurate cut off value with good diagnostic properties for Indian population.
Metrics
References
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104.
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manage. 2011;7:467-74.
Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Pregnancy-Induced hypertension. Hormones. 2015;14(2):211-23.
Soukup M, Biesiada I, Henderson A, Idowu B, Rodeback D, Ridpath L, et al. Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetol Metab Syndr. 2012;4(1):14.
Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011;58:704-8.
De Becker B, Borghi C, Burnier M, van de Borne P. Uric acid and hypertension: a focused review and practical recommendations. J Hypertens. 2019;37(5):878-83.
Johnson RJ, Kanbay M, Kang DH, Sánchez-Lozada LG, Feig D. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011;58(4):548-9.
Singh U, Solanki V, Mehrotra S, Sharma R. An evaluation of applicability of salivary uric acid measurement in preeclampsia and normal pregnancy and its correlation with serum uric acid. J Obstet Gynecol India. 2018;69(1):62-8.
Madaan S, Jaiswal A, Acharya N, Tayade S, Dhok A, Kumar S, et al. Role of salivary uric acid versus serum uric acid in predicting maternal complications of pre-eclampsia in a rural hospital in central India: a two-year, cross-sectional study. Cureus. 2022;14(3).
Anupama U, Meena D. Prediction of preeclampsia by mean arterial pressure and waist circumference. OBGYN. 2019;6(1):24-7.
Cnossen JS, Vollebregt KC, de Vrieze N, ter Riet G, Mol BWJ, Franx A, et al. Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ. 2008;336(7653):1117-20.
Walsh CA, Baxi LV. Mean arterial pressure and prediction of pre-eclampsia. BMJ. 2008;336(7653):1079-80.
Zhu J, Zhang J, Syaza Razali N, Chern B, Tan KH. Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study. BMJ Open. 2021;11(8):e046161.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315-6.
Hajian-Tilaki K. Receiver operating characteristic (roc) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4(2):627-35.
Mendola P, Mumford SL, Männistö TI, Holston A, Reddy UM, Laughon SK. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology. 2015;26(1):17-26.
Habli M, Levine RJ, Qian C, Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol. 2007;197(4):406.e1-7.
Downloads
Published
How to Cite
Issue
Section
